/PRNewswire/ Heska Corporation (NASDAQ: HSKA; "Heska" or "Company"), a leading global provider of advanced veterinary diagnostic and specialty products,.
Heska Corporation Reports Fourth Quarter and Full Year 2020 Results
Full Year Sales Up 60.9% - Fourth Quarter Sales Up 90.5% - Full Year Subscriptions Up 25%
2021 Outlook Revenue Raised, Key Strategic Initiatives Reaffirmed
News provided by
Share this article
Share this article
LOVELAND, Colo., Feb. 23, 2021 /PRNewswire/ Heska Corporation (NASDAQ: HSKA; Heska or Company ), a leading provider of advanced veterinary diagnostic and specialty products, reported financial results in two segments (North America and International) for its fourth quarter and full year ended December 31, 2020. Point of Care is POC and scil animal care company GmbH is scil in this release. The scil acquisition was completed April 1, 2020.
Share this article
Share this article
LOVELAND, Colo., Jan. 12, 2021 /PRNewswire/ Heska Corporation (NASDAQ: HSKA; Heska or Company ), a leading global provider of advanced veterinary diagnostic and specialty products, appointed Dr. Joachim Hasenmaier, the former head of Boehringer Ingelheim Animal Health, to the Company s Board of Directors, effective January 11, 2021.
Dr. Joachim Hasenmaier most recently served as a member of the board of managing directors of Boehringer Ingelheim, a world-leading, research-driven pharmaceutical company, where he oversaw the animal health and consumer healthcare businesses. Previously, as head of animal health of Boehringer Ingelheim, Dr. Hasenmaier led the rapid growth and expansion of the business, including the acquisition of a significant part of the Fort Dodge Animal Health product portfolio as well as the acquisition and integration of the Sanofi/Merial animal health units. Dr. Hasenmaier received his Doctor of Veterinary Medicine de
LOVELAND, Colo., Jan. 12, 2021 /PRNewswire/ Heska Corporation , a leading global provider of advanced veterinary diagnostic and specialty products, appointed Dr. Joachim Hasenmaier, the.